Dyslipidemia Drug Indications
Comparative chart of single and combination treatment options indicating which lipids can be targeted for dyslipidemias.
Cardiovascular Disease
Hypertension Treatment Algorithm
Management of hypertension in adults based on evidence-based guidelines.
Hypertension Evaluation
Blood pressure classification, diagnostic workup of hypertension, assess for major cardiovascular disease risk factors and identifiable causes, and blood pressure measurement techniques.
Hypertension Treatments: Diuretics
A comparative list of loop, potassium-sparing, and thiazide-like diuretics monotherapy and combination therapy for the treatment of hypertension.
Hypertension Treatments: ARBs
A comparative list of Angiotensin II Receptor Blockers (ARBs) monotherapy and combination therapy for the treatment of hypertension.
Anticoagulant Dosing Conversions
Recommended dosing conversions for anticoagulants such as warfarin, heparin, and dabigatran.
Physical Activity Reduces Risk of Death From Cancer and Cardiovascular Disease
In contrast with current guidelines, non-conventional physical activity patterns reduce all-cause, cardiovascular disease (CVD), and cancer mortality.
New Algorithm Adopted by NCCN for Reducing Cardiovascular Disease in Prostate Cancer
Clinicians may need to be more proactive in preventing and treating cardiovascular disease in patients with prostate cancer who are receiving ADT.
Stroke Risk Up Post-Cancer Diagnosis
Stroke risk found highest first three months after cancer diagnosis.
QTc Not Prolonged by Onartuzumab Plus Paclitaxel With or Without Bevacizumab
Onartuzumab with weekly paclitaxel with or without bevacizumab does not prolong the corrected QT (QTc) interval.
Next post in Side Effect Management
